103 related articles for article (PubMed ID: 3146662)
1. Effects of combination of vasodilator drugs and hypertonic solutions on methotrexate distribution into the rat brain.
Abe H
Jpn J Pharmacol; 1988 Nov; 48(3):373-6. PubMed ID: 3146662
[TBL] [Abstract][Full Text] [Related]
2. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
Pan GY; Liu XD; Liu GQ
Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
5. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
Neuwelt EA; Frenkel EP; Rapoport S; Barnett P
Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280
[TBL] [Abstract][Full Text] [Related]
6. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
7. Osmotic opening of the blood-brain barrier and local cerebral glucose utilization.
Pappius HM; Savaki HE; Fieschi C; Rapoport SI; Sokoloff L
Ann Neurol; 1979 Mar; 5(3):211-9. PubMed ID: 443753
[TBL] [Abstract][Full Text] [Related]
8. Bolus injection of hypertonic solutions for cerebral edema in rats: challenge of homeostasis of healthy brain.
Jiang W; Cao WJ; Zhang YK; Wei XY; Kuang F
Neurosci Lett; 2012 Feb; 509(1):44-9. PubMed ID: 22230889
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis.
Hasegawa H; Allen JC; Mehta BM; Shapiro WR; Posner JB
Neurology; 1979 Sep; 29(9 Pt 1):1280-6. PubMed ID: 573408
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
11. Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol.
Berger S; Schürer L; Härtl R; Messmer K; Baethmann A
Neurosurgery; 1995 Jul; 37(1):98-107; discussion 107-8. PubMed ID: 8587698
[TBL] [Abstract][Full Text] [Related]
12. [3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier.
Ohata M; Fredericks WR; Neuwelt EA; Sundaram U; Rapoport SI
Cancer Res; 1985 Mar; 45(3):1092-6. PubMed ID: 3971363
[TBL] [Abstract][Full Text] [Related]
13. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline.
Toung TJ; Hurn PD; Traystman RJ; Bhardwaj A
Crit Care Med; 2002 Mar; 30(3):644-9. PubMed ID: 11990928
[TBL] [Abstract][Full Text] [Related]
14. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.
Rapoport SI
Cell Mol Neurobiol; 2000 Apr; 20(2):217-30. PubMed ID: 10696511
[TBL] [Abstract][Full Text] [Related]
15. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
[TBL] [Abstract][Full Text] [Related]
17. [Hypertonic solutions and intracranial pressure].
Favre JB; Ravussin P; Chiolero R; Bissonnette B
Schweiz Med Wochenschr; 1996 Sep; 126(39):1635-43. PubMed ID: 8927967
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary vasodilator responses to nicardipine: comparison with other vasodilators.
Matot I; Neely CF
Crit Care Med; 1995 Nov; 23(11):1851-7. PubMed ID: 7587261
[TBL] [Abstract][Full Text] [Related]
19. 31P-NMR studies on time-course of change in the blood-brain barrier after treatment with hypertonic solution.
Sogabe T; Miura I
Biochim Biophys Acta; 1990 Mar; 1051(3):282-4. PubMed ID: 2155669
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol.
Bermueller C; Thal SC; Plesnila N; Schmid-Elsaesser R; Kreimeier U; Zausinger S
J Neurol Sci; 2006 Feb; 241(1-2):73-82. PubMed ID: 16343544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
